Mar 26, 2015
Surefire Medical, Inc., a commercial stage medical device company developing novel devices for minimally invasive, direct-to-tumor interventional procedures, announces that the company has won Jefferson County Economic Development Corporation’s...
Dec 16, 2014
Growing body of clinical evidence shows greater tumor penetration, targeted delivery, efficiency and cost savings with the Surefire device
Nov 27, 2012
First human trial for Tay-Sachs, Canavan and other rare enzyme deficiency diseases plans to begin in early 2013 thanks to NTSAD, the nation's oldest patient advocacy organization, which leads efforts to find a cure or treatment.